Cautionary Statement Regarding Forward-Looking Statements



This Quarterly Report on Form 10-Q contains forward-looking statements within
the meaning of the Securities Exchange Act of 1934 and the Securities Act of
1933, which are subject to risks and uncertainties. The forward-looking
statements include statements concerning, among other things, our business
strategy, financial and operating results, gross margins, liquidity and capital
expenditure requirements and impact of accounting standards. In some cases, you
can identify these statements by forward-looking words, such as "may," "might,"
"will," "could," "should," "expect," "plan," "anticipate," "believe,"
"estimate," "predict," "intend" and "continue," the negative or plural of these
words and other comparable terminology.

The forward-looking statements are only predictions based on our current
expectations and our projections about future events. All forward-looking
statements included in this Quarterly Report on Form 10-Q are based upon
information available to us as of the filing date of this Quarterly Report on
Form 10-Q. You should not place undue reliance on these forward-looking
statements. We have no obligation to update any of these statements. These
forward-looking statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity, performance
or achievements to differ materially from those expressed or implied by these
statements, including risks related to general market trends, uncertainties
related to COVID-19 and the impact of our responses to it, the interpretation
and impacts of changes in export controls and other trade barriers, our ability
to execute our business strategy and other risks discussed in the section titled
"Risk Factors" and elsewhere in our Annual Report on Form 10-K for the year
ended December 28, 2019 and in this Quarterly Report on Form 10-Q. You should
carefully consider the numerous risks and uncertainties described under these
sections.

The following discussion and analysis should be read in conjunction with our
condensed consolidated financial statements and the accompanying notes contained
in this Quarterly Report on Form 10-Q. Unless expressly stated or the context
otherwise requires, the terms "we," "our," "us" and "FormFactor" refer to
FormFactor, Inc. and its subsidiaries.

Overview

FormFactor, Inc., headquartered in Livermore, California, is a leading provider
of test and measurement solutions. We provide a broad range of high-performance
probe cards, analytical probes, probe stations, metrology systems, and thermal
sub-systems to both semiconductor companies and scientific institutions. Our
products provide electrical and optical information from a variety of
semiconductor and electro-optical devices and integrated circuits from research,
through development to production. Customers use our products and services to
lower production costs, improve yields, and enable development of their complex
next-generation products.

We operate in two reportable segments consisting of the Probe Cards segment and
the Systems segment. Sales of our probe cards and analytical probes are included
in the Probe Cards segment, while sales of our probe stations, metrology systems
and thermal sub-systems are included in the Systems segment.

We generated net income of $15.9 million in the first three months of fiscal
2020 as compared to $5.5 million in the first three months of fiscal 2019. The
increase in net income was primarily due to higher revenues, partially offset by
higher operating expenses, both generated by higher operating levels.

Impact of COVID-19



An outbreak of an illness caused by a novel coronavirus in 2019 ("COVID-19") has
resulted in millions of infections and well over one hundred thousand deaths
worldwide as of the date of filing this Quarterly Report. COVID-19 continues to
spread in many of the regions that we, our customers and our suppliers operate.
The COVID-19 pandemic has resulted in significant governmental measures being
implemented to control the spread of the virus, including the imposition of
stay-at-home and other orders in locations where we have manufacturing and other
activities. We experienced a significant disruption to our operations as a
result of the COVID-19 pandemic during the last two weeks of our first fiscal
quarter of 2020 which continues, although currently to a lessening extent.

We believe that we operate in a critical infrastructure industry, as defined by
the U.S. Department of Homeland Security. This reduces the current and
anticipated impacts of the COVID-19 pandemic on our major customers and
suppliers, and upon our operations, as compared to companies that are not part
of the critical infrastructure. After a temporary suspension of manufacturing to
implement safety measures in our California and Oregon locations, consistent
with federal guidelines and state and local orders, we recommenced
manufacturing. We currently continue to operate in all of our manufacturing
sites
                                       21
--------------------------------------------------------------------------------

subject to certain safety and related constraints. Our other operations are similarly continuing with substantial work-from-home activities.



If the provisions of governmental health orders or other safety requirements
continue for an extended period of time, or if we have occurrences of COVID-19
in any of our facilities, we may experience further disruptions or delays in
manufacturing, product design, product development, customer support,
manufacturing and sales, and an overall loss of productivity and efficiency. The
progression of the COVID-19 pandemic could also negatively impact our business
or results of operations through new restrictions at our operating locations or
at those of our customers or suppliers.

Even with our continued operations, COVID-19 has had, and may have further,
negative impacts on our supply chain, workforce and customers. As the COVID-19
pandemic is a widespread public health crisis, it is also adversely affecting
major economies and financial markets world-wide. A resulting economic downturn
can be expected to eventually negatively affect the demand for our products, and
contribute to volatile demand and supply conditions affecting the markets for
our products.

Governments in several countries where we operate, including the United States,
have enacted stabilization and stimulus measures in an effort to counteract some
of the impacts of COVID-19. We may benefit from some of these measures, although
we do not believe those benefits will have a material effect upon our financial
results or financial condition.

While to date the disruptions in our operations, supply chain and customer
demand as a result of the COVID-19 pandemic have been somewhat limited, we
believe that the COVID-19 pandemic represents a sustained threat that may
eventually give rise to a variety of more significant adverse impacts on our
business and financial results. We consider this as a near or longer term trend,
although we cannot identify or quantify the specific impacts given current
levels of uncertainty and the broad variety of effects that may arise from a
pandemic of this magnitude. For a further description of the uncertainties and
business risks associated with the COVID-19 pandemic, see the section entitled
"Risk Factors" in this Quarterly Report.

Critical Accounting Policies and the Use of Estimates



Management's Discussion and Analysis and Note 2 to the Consolidated Financial
Statements in our 2019 Annual Report on Form 10-K describe the significant
accounting estimates and critical accounting policies used in preparation of the
Consolidated Financial Statements. Actual results in these areas could differ
from management's estimates. During the three months ended March 28, 2020, there
were no significant changes in our critical accounting policies or estimates
from those reported in our Annual Report on Form 10-K for the year ended
December 28, 2019, which was filed with the Securities and Exchange Commission
on February 21, 2020.


                                       22

--------------------------------------------------------------------------------

Results of Operations



The following table sets forth our operating results as a percentage of revenues
for the periods indicated:

                                              Three Months Ended
                                           March 28,          March 30,
                                             2020               2019
Revenues                                         100.0  %       100.0  %
Cost of revenues                                  58.1           60.3
Gross profit                                      41.9           39.7
Operating expenses:
Research and development                          13.2           14.9
Selling, general and administrative               17.2           19.0

Total operating expenses                          30.4           33.9
Operating income                                  11.5            5.8
Interest income                                    0.4            0.4
Interest expense                                  (0.2)          (0.5)
Other expense, net                                (0.1)          (0.1)
Income before income taxes                        11.6            5.6
Provision for income taxes                         1.8            1.5
Net income                                         9.8  %         4.1  %


Revenues by Segment and Market


                   Three Months Ended
               March 28,       March 30,
                  2020            2019
                     (In thousands)
Probe Cards   $ 134,715       $ 108,103
Systems          26,038          24,110
              $ 160,753       $ 132,213



                                                                                            Three Months Ended
                                         March 28,                                    March 30,
                                            2020              % of Revenues              2019              % of Revenues           $ Change            % Change
                                                                                          (Dollars in thousands)

Probe Cards Markets:
Foundry & Logic                         $ 105,745                      65.8  %       $  71,580                      54.1  %       $ 34,165                 47.7  %
DRAM                                       24,696                      15.4             28,886                      21.9            (4,190)               (14.5)
Flash                                       4,274                       2.7              7,637                       5.8            (3,363)               (44.0)
Systems Market:
Systems                                    26,038                      16.1             24,110                      18.2             1,928                  8.0
Total revenues                          $ 160,753                     100.0  %       $ 132,213                     100.0  %       $ 28,540                 21.6  %



The increase in Foundry & Logic product revenue for the three months ended
March 28, 2020, compared to the three months ended March 30, 2019, was driven
principally by increased unit sales to large semiconductor foundries and
integrated device manufacturers, as they increased manufacturing of new chip
designs on leading-edge nodes.

The decrease in DRAM product revenue for the three months ended March 28, 2020,
compared to the three months ended March 30, 2019, was driven by decreased unit
sales as a result of decreased customer demand.

                                       23
--------------------------------------------------------------------------------

The decrease in Flash product revenue for the three months ended March 28, 2020,
compared to the three months ended March 30, 2019, was driven by decreased unit
sales as a result of decreased customer demand, as our revenue in this market
continues to be highly variable.

The increase in Systems product revenue for the three months ended March 28,
2020, compared to the three months ended March 30, 2019, was driven by increased
sales of probe stations, which includes an increase in revenue from 300mm
stations, partially offset by lower revenue from thermal sub-systems and 200mm
stations.

Due to COVID-19, there were various impacts across our segments due to
governmental mandates of social distancing. This resulted in a temporary factory
shut down for almost two weeks in certain locations, limiting our manufacturing
capacity. These shutdowns negatively affected revenue, especially in our Probes
segment.

Revenues by Geographic Region


                                      Three Months Ended
                     March 28,        % of        March 30,        % of
                        2020         Revenue         2019         Revenue
                                    (Dollars in thousands)
China               $  43,642         27.1  %    $  21,843         16.5  %
United States          31,916         19.9  %       34,263         25.9  %
Taiwan                 31,780         19.8  %       22,387         16.9  %
Europe                 21,043         13.1  %        9,493          7.2  %
South Korea            14,088          8.8  %       26,723         20.2  %
Japan                   8,370          5.2  %       10,432          7.9  %
Asia-Pacific1           7,863          4.9  %        3,263          2.5  %
Rest of the world       2,051          1.2  %        3,809          2.9  %
Total revenues      $ 160,753        100.0  %    $ 132,213        100.0  %


1 Asia-Pacific includes all countries in the region except China, Japan, South Korea and Taiwan, which are disclosed separately.



Geographic revenue information is based on the location to which we ship the
product. For example, if a certain South Korean customer purchases through their
U.S. subsidiary and requests the products to be shipped to an address in South
Korea, this sale will be reflected in the revenue for South Korea rather than
the U.S.

Changes in revenue by geographic region for the three months ended March 28, 2020, compared to the three months ended March 30, 2019, was primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, and product sales mix.

Cost of Revenues and Gross Margins



Cost of revenues consists primarily of manufacturing materials, compensation and
benefits, shipping and handling costs, manufacturing-related overhead and
amortization of certain intangible assets. Our manufacturing operations rely on
a limited number of suppliers to provide key components and materials for our
products, some of which are a sole source. We order materials and supplies based
on backlog and forecasted customer orders. Tooling and setup costs related to
changing manufacturing lots at our suppliers are also included in the cost of
revenues. We expense all warranty costs, inventory provisions and amortization
of certain intangible assets as cost of revenues.

Our gross profit and gross margin were as follows (dollars in thousands):


                                 Three Months Ended
                March 28,      March 30,
                  2020           2019         $ Change       % Change
Gross profit   $ 67,390       $ 52,521       $ 14,869          28.3  %
Gross margin       41.9  %        39.7  %



                                       24

--------------------------------------------------------------------------------

Our gross profit and gross margin by segment were as follows (dollars in
thousands):
                                                                                         Three Months Ended
                                                  March 28, 2020                                                                                                        March 30, 2019
                                                             Corporate and                                                                Corporate and
                       Probe Cards           Systems             Other              Total           Probe Cards           Systems             Other                Total
Gross profit          $    60,743          $ 13,334          $   (6,687)         $ 67,390          $    45,294          $ 13,016          $   (5,789)         $      52,521
Gross margin                 45.1  %           51.2  %                -  %           41.9  %              41.9  %           54.0  %                -  %                39.7  %



Probe Cards
For the three months ended March 28, 2020, gross profit and gross margins
increased compared to the three months ended March 30, 2019, primarily due to
increased sales and higher factory utilization.

Systems


For the three months ended March 28, 2020, gross profit increased while gross
margin decreased compared to the three months ended March 30, 2019, primarily as
a result of product mix and additional contribution from our acquisition of FRT
GmbH.

Corporate and Other
Corporate and Other includes unallocated expenses relating to amortization of
intangible assets, share-based compensation, and restructuring charges, net,
which are not used in evaluating the results of, or in allocating resources to,
our reportable segments.

Overall


Gross profit and gross margin fluctuate with revenue levels, product mix,
selling prices, factory loading and material costs. For the three months ended
March 28, 2020, compared to the three months ended March 30, 2019, gross profit
and gross margins have improved, primarily on higher sales.

Cost of revenues included stock-based compensation expense as follows (in thousands):


                                  Three Months Ended
                            March 28,             March 30,
                               2020                 2019
Stock-based compensation   $    937              $    950



Future gross margins may be adversely impacted by lower revenues, unfavorable
product mix and lower factory utilization. Our gross margins may also be
adversely affected if we are required to record additional inventory write-downs
for estimated average selling prices that are below cost or because of a
decrease in demand.

Research and Development
                                             Three Months Ended
                            March 28,      March 30,
                              2020           2019         $ Change      % Change
                                           (Dollars in thousands)
Research and development   $ 21,267       $ 19,723       $ 1,544           7.8  %
% of revenues                  13.2  %        14.9  %

The increase in research and development expenses in the three months ended March 28, 2020 when compared to the corresponding period in the prior year was primarily driven by increased headcount combined with higher variable compensation, partially offset by a decrease in project material costs.


                                       25
--------------------------------------------------------------------------------

A detail of the changes is as follows (in thousands):


                                                                                        Three Months
                                                                                        Ended March
                                                                                          28, 2020
                                                                                        compared to
                                                                                        Three Months
                                                                                        Ended March
                                                                                          30, 2019
Employee compensation costs                                                            $     1,649
Depreciation                                                                                    88
Stock-based compensation                                                                       (80)
Project material costs                                                                         (65)
Other general operations                                                                       (48)
                                                                                       $     1,544



Research and development included stock-based compensation expense as follows
(in thousands):
                               Three Months Ended
                            March 28,       March 30,
                               2020           2019
Stock-based compensation   $   1,439       $  1,519

Selling, General and Administrative


                                                         Three Months Ended
                                        March 28,      March 30,
                                          2020           2019         $ Change      % Change
                                                       (Dollars in thousands)

Selling, general and administrative $ 27,693 $ 25,184 $ 2,509 10.0 % % of revenues

                              17.2  %        19.0  %


The increase in selling, general and administrative in the three months ended
March 28, 2020 when compared to the corresponding period in the prior year was
primarily due to increased headcount combined with higher variable compensation,
higher stock-based compensation related to the timing of annual grants, and
higher costs from acquisition of FRT GmbH, offset partially by a decrease in the
amortization of intangible assets.

A detail of the changes is as follows (in thousands):


                                                                                        Three Months
                                                                                        Ended March
                                                                                          28, 2020
                                                                                        compared to
                                                                                        Three Months
                                                                                        Ended March
                                                                                          30, 2019
Employee compensation                                                                        1,942
Amortization of intangibles                                                                   (858)
Consulting fees                                                                                566
Stock-based compensation                                                                       421
General operating expenses                                                                     438
                                                                                       $     2,509



Selling, general and administrative included stock-based compensation expense as
follows (in thousands):
                               Three Months Ended
                            March 28,       March 30,
                               2020           2019
Stock-based compensation   $   3,247       $  2,826



                                       26

--------------------------------------------------------------------------------

Interest Income and Interest Expense


                                                           Three Months Ended
                                                       March 28,        March 30,
                                                          2020             2019
                                                         (Dollars in thousands)
Interest Income                                      $       685       $     580

Weighted average balance of cash and investments $ 210,791 $ 151,451 Weighted average yield on cash and investments

              1.68  %         2.03  %

Interest Expense                                     $       318       $     595
Average debt outstanding                             $    42,854       $  64,835
Weighted average interest rate on debt                      2.50  %         

4.51 %





Interest income is earned on our cash, cash equivalents, restricted cash and
marketable securities. The increase in interest income for the three months
ended March 28, 2020 compared with the corresponding period of the prior year
was attributable to higher invested balances and sustained investment yields,
related in part to longer duration investments.

Interest expense primarily includes interest on our term loans, partially offset
by income from our interest-rate swap derivative contracts, as well as term loan
issuance costs amortization charges. The decrease in interest expense for the
three months ended March 28, 2020 compared to the same period of the prior year
was primarily due to lower outstanding debt balances related to the acquisition
of Cascade Microtech in fiscal 2016 as a result of principal payments made,
partially offset by additional interest expense related to the term loan
originated to finance the acquisition of FRT GmbH in the fourth quarter of 2019.

Other Expense, Net
Other expense, net, primarily includes the effects of foreign currency impact
and various other gains and losses.

Provision for Income Taxes


                                             Three Months Ended
                                   March 28,                          March 30,
                                     2020                               2019
                                     (In thousands, except percentages)
Provision for income taxes   $           2,816                       $  2,032
Effective tax rate                        15.1   %                       27.0  %



Provision for income taxes reflects the tax provision on our operations in
foreign and U.S. jurisdictions, offset by tax benefits from tax credits and the
foreign-derived intangible income ("FDII") deduction. We expect the FDII
deduction and corresponding benefit to be available after utilizing our previous
net operating loss carryforwards, resulting in a decrease in our effective tax
rate for the three months ended March 28, 2020, compared to the three months
ended March 30, 2019. Our effective tax rate may vary from period to period
based on changes in estimated taxable income or loss by jurisdiction, changes to
the valuation allowance, changes to U.S. federal, state or foreign tax laws,
future expansion into areas with varying country, state, and local income tax
rates, deductibility of certain costs and expenses by jurisdiction.


Liquidity and Capital Resources



Capital Resources
Our working capital was $308.8 million at March 28, 2020, compared to $282.5
million at December 28, 2019.

Cash and cash equivalents primarily consist of deposits held at banks and money
market funds. Marketable securities primarily consist of U.S. treasuries, U.S.
agency securities and corporate bonds. We typically invest in highly-rated
securities with low probabilities of default. Our investment policy requires
investments to be rated single A or better, and limits the types of acceptable
investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately
$239.4 million at March 28, 2020, compared to $220.9 million at December 28,
2019. We believe that we will be able to satisfy our working capital
requirements and scheduled term loan repayments for at least the next twelve
months with the liquidity provided by our existing cash, cash
                                       27
--------------------------------------------------------------------------------

equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-term debt obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.



The COVID-19 pandemic has negatively impacted the global economy, disrupted
global supply chains and created significant volatility and disruption of
financial markets. An extended period of global supply chain and economic
disruption could materially affect our business, results of operations, access
to sources of liquidity and financial condition. As a result of the current and
uncertain future impact of COVID-19, we have taken actions to preserve and
improve our liquidity primarily by limiting our exposures to volatile markets
and investments, as well as actively working to minimize counterparty risk.

If we are unsuccessful in maintaining or growing our revenues, maintaining or
reducing our cost structure (in response to a potential reduction in demand due
to an industry downturn, COVID-19, or other event), or increasing our available
cash through debt or equity financings, our cash, cash equivalents and
marketable securities may decline in fiscal 2020.

We utilize a variety of tax planning and financing strategies to manage our
worldwide cash and deploy funds to locations where needed. As part of these
strategies, we indefinitely reinvest a portion of our foreign earnings. Should
we require additional capital in the United States, we may elect to repatriate
indefinitely-reinvested foreign funds or raise capital in the United States.

Cash Flows
The following table sets forth our net cash flows from operating, investing and
financing activities:
                                                 Three Months Ended
                                              March 28,      March 30,
                                                2020           2019
                                                   (In thousands)

Net cash provided by operating activities $ 39,339 $ 20,638 Net cash used in investing activities (5,442) (9,332) Net cash used in financing activities $ (9,071) $ (3,932)





Operating Activities
Net cash provided by operating activities for the three months ended March 28,
2020 was primarily attributable to net income of $15.9 million and $22.7 million
of net non-cash expenses, offset by changes in operating assets and liabilities,
as explained below.

Accounts receivable, net, decreased $7.8 million to $90.1 million at March 28,
2020, compared to $97.9 million at December 28, 2019, as a result of changes in
customer sales mix, timing of customer shipments and timing of customer
payments.

Inventories, net, decreased $4.3 million to $79.0 million at March 28, 2020,
compared to $83.3 million at December 28, 2019, as a result of shipping prior
quarter backlog, lower inventory production, and less inventory receipts at the
end of the quarter primarily due to reduced operating levels under COVID-19
restrictions, as previously described.

Accrued liabilities decreased $7.3 million to $29.2 million at March 28, 2020, compared to $36.4 million at December 28, 2019, as a result of timing of payments including employee performance-based compensation and indirect taxes.



Investing Activities
Net cash used in investing activities for the three months ended March 28, 2020
was primarily related to $12.1 million of cash used in the acquisition of
property, plant and equipment partially offset by $6.6 million of net proceeds
from sales of marketable securities.

Financing Activities
Net cash used in financing activities for the three months ended March 28, 2020
primarily related to $13.2 million of principal payments made towards the
repayment of our term loans and $0.4 million related to tax withholding
associated with the net share settlements of our equity awards, partially offset
by $4.5 million of proceeds received from issuances of common stock under our
employee stock purchase plan and stock option plans.



                                       28
--------------------------------------------------------------------------------

Debt



CMI Term Loan
On June 24, 2016, we entered into a Credit Agreement (the "Credit Agreement")
with HSBC Bank USA, National Association ("HSBC"), as administrative agent,
co-lead arranger, sole bookrunner and syndication agent, other lenders that may
from time-to-time be a party to the Credit Agreement, and certain
guarantors. Pursuant to the Credit Agreement, the lenders have provided us with
a senior secured term loan facility of $150 million (the "CMI Term Loan"). The
proceeds of the CMI Term Loan were used to finance a portion of the purchase
price paid in connection with the Cascade Microtech acquisition in fiscal 2016
and to pay related bank fees and expenses.

The CMI Term Loan bears interest at a rate equal to, at our option, (i) the
applicable London Interbank Offered Rate ("LIBOR") rate plus 2.00% per annum or
(ii) Base Rate (as defined in the Credit Agreement) plus 1.00% per annum. We
have currently elected to pay interest at 2.00% over the one-month LIBOR rate.
Interest payments are payable in monthly installments over a five-year period.
The interest rate at March 28, 2020 was 3.61%.

The principal payments on the CMI Term Loan are paid in equal quarterly
installments that began June 30, 2016, in an annual amount equal to 5% for year
one, 10% for year two, 20% for year three, 30% for year four and 35% for year
five. The planned final payment on the CMI Term Loan is scheduled for the third
quarter of fiscal 2020.

On July 25, 2016, we entered into an interest rate swap agreement with HSBC and
other lenders to hedge the interest payments on the CMI Term Loan for the
notional amount of $95.6 million. As future levels of LIBOR over the life of the
loan are uncertain, we entered into these interest-rate swap agreements to hedge
the exposure in interest rate risks associated with movement in LIBOR rates. By
entering into the agreements, we convert a floating rate interest at one-month
LIBOR plus 2% into a fixed rate interest at 2.939%. The interest rate swap
agreement ended as of March 28, 2020.

The obligations under the Term Loan are guaranteed by substantially all of our
assets and the assets of our domestic subsidiaries, subject to certain customary
exceptions.

The Credit Agreement contains negative covenants customary for financing of this
type, as well as certain financial maintenance covenants. As of March 28, 2020,
the balance outstanding pursuant to the CMI Term Loan was $23.7 million and we
were in compliance with all covenants under the Credit Agreement.

FRT Term Loan
On October 25, 2019, we entered into a $23.4 million three-year credit facility
loan agreement (the "FRT Term Loan") with HSBC Trinkaus & Burkhardt AG, Germany,
to fund the acquisition of FRT GmbH, which we acquired on October 9, 2019. See
Note 4 for further details of the acquisition.

The FRT Term Loan bears interest at a rate equal to the Euro Interbank Offered
Rate ("EURIBOR") plus 1.75 % per annum and will be repaid in quarterly
installments of approximately $1.9 million plus interest beginning January 25,
2020.

The obligations under the FRT Term Loan are fully and unconditionally guaranteed
by FormFactor, Inc. The Credit Facility contains negative covenants customary
for financing of this type, including covenants that place limitations on the
incurrence of additional indebtedness, the creation of liens, the payment of
dividends; dispositions; fundamental changes, including mergers and
acquisitions; loans and investments; sale leasebacks; negative pledges;
transactions with affiliates; changes in fiscal year; sanctions and anti-bribery
laws and regulations, and modifications to charter documents in a manner
materially adverse to the Lenders. The FRT Term Loan also contains affirmative
covenants and representations and warranties customary for financing of this
type. As of March 28, 2020, the balance outstanding pursuant to the FRT term
loan was $21.4 million and we were in compliance with all covenants.

Contractual Obligations and Commitments



Other than our operating lease commitments as disclosed in Note 12 of Notes to
Condensed Consolidated Financial Statements, our contractual obligations and
commitments have not materially changed as of March 28, 2020 from those
disclosed in our Annual Report on Form 10-K for the year ended December 28,
2019.

Off-Balance Sheet Arrangements



Historically, we have not participated in transactions that have generated
relationships with unconsolidated entities or financial partnerships, such as
entities often referred to as structured finance or special purpose entities,
which would have been
                                       29
--------------------------------------------------------------------------------

established for the purpose of facilitating off-balance sheet arrangements or
other contractually narrow or limited purposes. As of March 28, 2020, we were
not involved in any such off-balance sheet arrangements.

Recent Accounting Pronouncements

See Note 1 of Notes to Condensed Consolidated Financial Statements.

© Edgar Online, source Glimpses